240 related articles for article (PubMed ID: 31831821)
1. FABP5 coordinates lipid signaling that promotes prostate cancer metastasis.
Carbonetti G; Wilpshaar T; Kroonen J; Studholme K; Converso C; d'Oelsnitz S; Kaczocha M
Sci Rep; 2019 Dec; 9(1):18944. PubMed ID: 31831821
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-κB) signaling in cancer cells.
Senga S; Kobayashi N; Kawaguchi K; Ando A; Fujii H
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1057-1067. PubMed ID: 29906613
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability.
Powell CA; Nasser MW; Zhao H; Wochna JC; Zhang X; Shapiro C; Shilo K; Ganju RK
Oncotarget; 2015 Mar; 6(8):6373-85. PubMed ID: 25779666
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter.
Forootan FS; Forootan SS; Gou X; Yang J; Liu B; Chen D; Al Fayi MS; Al-Jameel W; Rudland PS; Hussain SA; Ke Y
Oncotarget; 2016 Feb; 7(8):9322-39. PubMed ID: 26814431
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel/cabazitaxel and fatty acid binding protein 5 inhibitors produce synergistic inhibition of prostate cancer growth.
Carbonetti G; Converso C; Clement T; Wang C; Trotman LC; Ojima I; Kaczocha M
Prostate; 2020 Jan; 80(1):88-98. PubMed ID: 31661167
[TBL] [Abstract][Full Text] [Related]
6. FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism.
Zhang C; Liao Y; Liu P; Du Q; Liang Y; Ooi S; Qin S; He S; Yao S; Wang W
Theranostics; 2020; 10(15):6561-6580. PubMed ID: 32550890
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5.
Nitschke K; Erben P; Waldbillig F; Abdelhadi A; Weis CA; Gottschalt M; Wahby S; Nuhn P; Boutros M; Michel MS; von Hardenberg J; Worst TS
World J Urol; 2020 Mar; 38(3):637-645. PubMed ID: 30701334
[TBL] [Abstract][Full Text] [Related]
8. Utilization of adipocyte-derived lipids and enhanced intracellular trafficking of fatty acids contribute to breast cancer progression.
Yang D; Li Y; Xing L; Tan Y; Sun J; Zeng B; Xiang T; Tan J; Ren G; Wang Y
Cell Commun Signal; 2018 Jun; 16(1):32. PubMed ID: 29914512
[TBL] [Abstract][Full Text] [Related]
9. Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for prostate cancer in mouse xenografts.
Forootan SS; Bao ZZ; Forootan FS; Kamalian L; Zhang Y; Bee A; Foster CS; Ke Y
Int J Oncol; 2010 Jan; 36(1):69-76. PubMed ID: 19956834
[TBL] [Abstract][Full Text] [Related]
10. FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression.
Ye M; Hu C; Chen T; Yu P; Chen J; Lu F; Xu L; Zhong Y; Yan L; Kan J; Bai J; Li X; Tian Y; Tang Q
Int J Biol Sci; 2023; 19(10):3115-3127. PubMed ID: 37416772
[TBL] [Abstract][Full Text] [Related]
11. P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth.
Gang X; Yang Y; Zhong J; Jiang K; Pan Y; Karnes RJ; Zhang J; Xu W; Wang G; Huang H
Oncotarget; 2016 Mar; 7(12):15135-49. PubMed ID: 26934656
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid binding protein 5 regulates lipogenesis and tumor growth in lung adenocarcinoma.
Garcia KA; Costa ML; Lacunza E; Martinez ME; Corsico B; Scaglia N
Life Sci; 2022 Jul; 301():120621. PubMed ID: 35545133
[TBL] [Abstract][Full Text] [Related]
13. Dual role of fatty acid-binding protein 5 on endothelial cell fate: a potential link between lipid metabolism and angiogenic responses.
Yu CW; Liang X; Lipsky S; Karaaslan C; Kozakewich H; Hotamisligil GS; Bischoff J; Cataltepe S
Angiogenesis; 2016 Jan; 19(1):95-106. PubMed ID: 26625874
[TBL] [Abstract][Full Text] [Related]
14. [FABP5 promotes cell growth, invasion and metastasis in cervical cancer].
Zhan YZ; Liu F; Zhang Y; Mo XY; Cheng WD; Wang W
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):200-207. PubMed ID: 30917456
[No Abstract] [Full Text] [Related]
15. FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β-catenin pathway.
Lu F; Ye M; Hu C; Chen J; Yan L; Gu D; Xu L; Tian Y; Bai J; Tang Q
Cancer Sci; 2023 Sep; 114(9):3553-3567. PubMed ID: 37302809
[TBL] [Abstract][Full Text] [Related]
16. Fatty Acid-Binding Protein 5 Mediates the Uptake of Fatty Acids, but not Drugs, Into Human Brain Endothelial Cells.
Lee GS; Pan Y; Scanlon MJ; Porter CJH; Nicolazzo JA
J Pharm Sci; 2018 Apr; 107(4):1185-1193. PubMed ID: 29247738
[TBL] [Abstract][Full Text] [Related]
17. The FABP12/PPARγ pathway promotes metastatic transformation by inducing epithelial-to-mesenchymal transition and lipid-derived energy production in prostate cancer cells.
Liu RZ; Choi WS; Jain S; Dinakaran D; Xu X; Han WH; Yang XH; Glubrecht DD; Moore RB; Lemieux H; Godbout R
Mol Oncol; 2020 Dec; 14(12):3100-3120. PubMed ID: 33031638
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of fatty acid binding protein 5 (FABP5) in cancers.
George Warren W; Osborn M; Yates A; Wright K; O'Sullivan SE
Drug Discov Today; 2023 Jul; 28(7):103628. PubMed ID: 37230284
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5.
Al-Jameel W; Gou X; Forootan SS; Al Fayi MS; Rudland PS; Forootan FS; Zhang J; Cornford PA; Hussain SA; Ke Y
Oncotarget; 2017 May; 8(19):31041-31056. PubMed ID: 28415688
[TBL] [Abstract][Full Text] [Related]
20. Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression.
Uehara H; Takahashi T; Oha M; Ogawa H; Izumi K
Int J Cancer; 2014 Dec; 135(11):2558-68. PubMed ID: 24740818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
